跳至主要内容
临床试验/ACTRN12623001037695
ACTRN12623001037695尚未招募Unknown

Maternal OXygen Immediately before birth: The MOXIE feasibility study

Douglas Blank0 个研究点目标入组 40 人开始时间: 2023年9月26日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • Expecting women between 32 weeks and 0 days to 41 weeks and 6 days gestational age giving birth

排除标准

  • History of severe maternal epistaxis
  • History of major nasal/sinus surgery or pathology
  • Concurrent maternal chronic obstructive pulmonary disease (COPD) exacerbation
  • Fetus with congenital abnormality that would alter the expected SpO2 targets in the minutes after birth; ie antenatal diagnosis of ductal dependant cardiac lesions, congenital diaphragmatic hernia, etc.
  • Monochorionic twins with evidence of twin-to-twin transfusion syndrome or multiples of more than 2.

研究者

发起方
Douglas Blank

相似试验